PRRT2 and hepatocellular carcinoma: Therefore, immunoblotting was conducted to characterize the expression of PKC isoforms in HepG2 cells and explore whether ISJ and compound 7 represent potential candidates for selective PKC expression inhibitors in hepatoma.